| Catalog No. |
Size |
Price |
Figures |
|---|
Z00005-1 mg
| 1 mg | $ 420.00 |
References:
- Haro I, et al. Liposome entrapment and immunogenic studies of a synthetic lipophilic multiple antigenic peptide bearing VP1 and VP3 domains of the hepatitis A virus: a robust method for vaccine design. FEBS Lett. Apr 2003; 540(1-3): 133-140.
- Kanda T, et al. Hepatitis A virus VP3 may activate serum response element associated transcription. Scand. J. Gastroenterol. Mar 2003; 38(3): 307-313.
- Sospedra P, et al. Interaction study of peptide from VP3 capsid protein of hepatitis A virus through monolayers and fluorescence spectroscopy. Luminescence. Mar-Apr 2001; 16(2): 103-107.
|
|---|
| Full Name | | Hepatitis A Virus (HAV) VP3 |
|
| Abbreviated Name-1 | HAV-VP3 |
|---|
| Abbreviated Name-2 | Hepatitis A Virus VP3 |
|---|
| Description | The protein Hepatitis A Virus (HAV) VP3 contains the HAV VP3 immunodominant regions, amino acids: 304-415. |
|---|
| Source | E. coli |
|---|
| M.W. | 29,000 Da |
|---|
| Purity | Protein is >90% pure as determined by 10% PAGE (coomassie staining). |
|---|
| Storage | Protein is shipped at ambient temperature. Upon arrival, store at -20°C. |
|---|
| Concentration | 1 mg/ml in 10 mM CBB, pH 9.6, 0.1% SDS, 50% glycerol |
|---|
| Stability | Five years frozen, one month in solution at room temperature |
|---|
| Specificity | Immunoreactive with sera of HAV-infected individuals |
|---|
| Applications | Antigen in ELISA and Western blots, excellent antigen for detection of HAV with minimal specificity problems. |
|---|
